DJIA 17,731.65 -66.84 -0.38%
NASDAQ 5,106.46 -21.07 -0.41%
S&P 500 2,082.82 -7.29 -0.35%
market minute promo

Allergen PLC (NYSE: AGN)

313.55 -6.21 (-1.94%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AGN $313.55 -1.94%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $319.36
Previous Close $319.76
Daily Range $313.01 - $319.76
52-Week Range $237.50 - $340.34
Market Cap $123.6B
P/E Ratio -47.23
Dividend (Yield) $0.00 (0.0%)
Volume 1,668,340
Average Daily Volume 6,090,210
Current FY EPS $15.40




Drug Makers

Allergen PLC (AGN) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website:

News & Commentary Rss Feed

3 Companies That Could Become Tax Inversion Targets

The Pfizer-Allergan deal may not be the last tax inversion deal we witness. These three companies could also become the target of a U.S.-based buyer.

M&A Emerges From Tryptophan Stupor

Pfizer-Allergan Merger: More Than A U.S. Tax Dodge? (Video)

Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2015 Update

Stock Market News for November 27, 2015

New Strong Sell Stocks for November 27th

Is Pfizergan Really That Unpalatable?

Can investors learn to like the proposed merger between pharma giants Allergan and Pfizer?

Premarket Biotech Digest: Clovis A Buy, Cellceutix Rallies, Pfizer's Avelumab Milestone

Tracking Stephen Mandel's Lone Pine Capital Portfolio - Q3 2015 Update

Allergan drops appeal of order blocking Alzheimer's drug switch

See More AGN News...

AGN's Top Competitors

AGN $313.55 (-1.94%)
Current stock: AGN
JNJ $101.70 (-0.65%)
Current stock: JNJ
PFE $32.61 (-0.55%)
Current stock: PFE
NVS $85.20 (-0.75%)
Current stock: NVS